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IDENTIFIKASI BIOMARKER PROTEIN YANG BERPOTENSI DARIPADA 
BIOFILEM Salmonella enterica subspecies enterica serovar Typhi 
 
ABSTRAK 
Salmonella Typhi adalah patogen demam kepialu yang hanya menjangkiti manusia. 
Ia merupakan masalah kesihatan yang serius di negara-negara yang sedang 
membangun termasuk Malaysia. Walaupun langkah pencegahan dan rawatan 
perubatan telah dijalankan, tetapi wabak demam kepialu masih berlaku. Salah satu 
faktor yang menyumbang kepada keterusan deman kepialu adalah kewujudan 
pembawa (carrier) deman kepialu yang tiada tanda-tanda klinikal. Wujudnya 
pembawa deman kepialu adalah dijangka melibatkan biofilem yang terbentuk di 
dalam pudi hempedu pesakit. Pembentukan biofilem membolehkan bakteria tersebut 
mengelak serangan sistem imun mangsanya dan ubat antibiotik. Dalam usaha untuk 
memahami pembentukan biofilem, satu kaedah untuk kultur S. Typhi biofilem in 
vitro telah dicipta untuk memudahcarakan kajian ekpresi protein dan kekebalan 
biofilem terhadap antibiotik. 
 
Dalam kajian ini, S. Typhi telah dikultur secara in vitro dengan menyamai 
persekitaran dalam pundi hempedu manusia dengan menggunakan media kultur yang 
mengandungi sup nutrien, glukosa, hempedu dan garam. Protein biofilem yang 
dihasilkan dianalisis secara perbandingan dengan pasangan planktoniknya 
menggunakan kaedah 2D-PAGE. Daripada analisis tersebut, telah didapati lima-
belas titik-titik protein yang unik kepada biofilem. Titik-titik protein yang unik telah 
diekstrakkan dan identitinya dikenalpasti dengan mengunakan kaedah MALDI-TOF. 
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Salah satu daripada titik-titik protein unik tersebut merupakan protein TolC, iaitu 
salah satu faktor yang menyumbang kepada kebisaan dan kerintangan bakteria 
tersebut. Selain daripada itu, ia juga didapati meningkatkan tahap ekpresinya (TolC) 
secara empirikal apabila terdedah kepada hempedu dalam media kultur biofilem. 
Tahap kerintangan biofilem juga dinilai dengan kajian cabaran antibiotik (antibiotic 
sensitivity test) termasuk ampicillin, chloramphenicol, kanamycin dan tetracycline. 
Penilaian kekebalan menunjukkan bahawa biofilem S. Typhi memang lebih kebal 
terhadap kebanyakan antibiotik seperti chloramphenicol, kanamycin, dan 
tetracycline, tetapi masih sensitif kepada ampicillin. 
 
Kaedah pengkulturan S. Typhi biofilem yang dikenal pasti dalam kajian ini boleh 
digunakan sebagai model kajian in vitro pembawa deman kepialu dan juga satu 
kaedah untuk mengkaji kuantiti antibiotik yang diperlukan untuk menghapuskan 
biofilem yang berada di dalam pesakit kronik. Protein biofilem yang dikenalpasti 
dalam kajian ini merupakan calon-calon biomarker yang berpotensi untuk dijadikan 
ujian diagnostik bagi mengenal-pasti pembawa deman kepialu. Selain daripada itu, S. 
Typhi biofilem merupakan bidang penyelidikan yang baru, dan ilmu pengetahuan 
yang telah dijana daripada kajian ini boleh menambahkan nilai yang lebih ketara 
kepada pemahaman mekanisma pembentukan biofilem. 
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IDENTIFICATION OF POTENTIAL PROTEIN BIOMARKERS FROM 
Salmonella enterica subspecies enterica serovar Typhi BIOFILM 
 
ABSTRACT 
Salmonella Typhi is a human specific pathogen which causes typhoid fever. It is a 
major health problem in developing countries including Malaysia. Although 
prevention and medical treatment are available, typhoid still persists. One of the 
major factors contributing to typhoid persistence is the existence of asymptomatic 
typhoid carriers. Biofilm formation in the human gallbladder is postulated to be 
associated with development of carriers. Formation of biofilm enables the bacteria to 
evade the host immune system and resist antibiotics. In order to understand the 
formation of biofilm, a S. Typhi biofilm culture method was developed to facilitate 
the biofilm protein expression and antibiotic resistance studies.  
 
In this study, S. Typhi biofilm was cultured in vitro by mimicking the human 
gallbladder environment using nutrient broth containing bile, glucose, and salts. 
Biofilm proteins were harvested and compared with the planktonic counterpart using 
2D-PAGE. Fifteen unique biofilm protein spots were identified and were excised for 
further analysis using MALDI-TOF. One of the biofilm proteins identified was TolC, 
a virulence and persistence factor of the bacteria. It was also found to be empirically 
upregulated in response to bile concentration in the biofilm culture medium. Biofilm 
antibiotic resistance was assessed by challenging the biofilm bacteria cells with 
ampicillin, chloramphenicol, kanamycin, and tetracycline.  The results showed that S. 
Typhi biofilm was generally more resistant to certain antibiotics such as 
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chloramphenicol, kanamycin, and tetracycline, but remained susceptible to 
ampicillin. 
 
The S. Typhi biofilm culture method developed in this study could be used as a 
model for the typhoid carrier stage and also to screen antibiotics required for 
elimination of S. Typhi biofilm in chronic patients. Biofilm proteins identified in this 
study are potential biomarker candidates for typhoid carrier identification. 
Furthermore, since S. Typhi biofilm is a new research field, knowledge generated in 
this study added significant value to the knowledge pool of biofilm and provide clues 
for better understanding of the mechanism of biofilm formation. 
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CHAPTER 1.0  
INTRODUCTION 
 
1.1 Salmonella enterica subspecies enterica serovar Typhi  
Salmonella enterica subspecies enterica serovar Typhi (S. Typhi) is the pathogen 
responsible for typhoid fever in humans. It is a human-specific pathogen which preys 
specifically on humans, which also serve as their reservoir. It is a Gram negative 
bacteria which belongs to the genus Salmonella, a pathogen which is not present in 
the normal gut of humans. The size of the bacteria is approximately 2-3 µm in length 
and 0.4-0.6 µm in diameter (WHO, 2003). In the laboratory, S. Typhi exists as motile 
cells with peritrichous flagella. Like most bacteria, S. Typhi is a chemoorganotroph, 
i.e. they obtain energy and carbon molecules needed for cellular functions from 
organic compounds (Clark & Barrett, 1987). 
 
1.1.1  Nomenclature of Salmonella 
The nomenclature of Salmonella is a very complex system which consists of over 
two thousand serovars and the numbers are still growing with newly identified 
serovars every year (Su & Chiu, 2007). Salmonella is named after its founder Daniel 
Elmer Salmon, an American bacteriologist who first isolated Salmonella from 
porcine intestine in 1884. The isolated Salmonella was called Salmonella 
Choleraesuis (Schultz, 2008). Salmonella is classified based on serological typing 
using specific antisera recommended by Kauffmann in the year 1966. Salmonella 
identified after 1966 were designated based on serotyping results. However, there are 
a few clinically important serovars, such as S. Typhi and S. London which were 
identified before 1966 and given special names based on the location the bacteria 
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was first isolated instead of following the antigenic formula system (Su & Chiu, 
2007). To avoid confusion and to accommodate all the Salmonella strains, the 
nomenclature system underwent years of reformation. Salmonella nomenclature 
remains a discussion topic till this day.  
 
Presently, according to the ruling of the Judicial Commission of the International 
Committee on Systemic Bacteriology, the genus Salmonella consist of three species, 
Salmonella bongori, Salmonella enterica and Salmonella subterranean. Salmonella 
enterica was further divided into six subspecies: 1) S. enterica subspecies enterica; 
2) S. enterica subspecies salamae; 3) S. enterica subspecies arizonae; 4) S. enterica 
subspecies diarizonae; 5) S. enterica subspecies houtenae and 6) S. enterica 
subspecies indica. Serovar strains in subspecies I are mostly clinical pathogen 
identified before serotyping was introduced which include S. Typhi, S. 
Typhimurium, and S. Enteritidis etc. (Table 1.1). 
 
Although Salmonella species subterranean was officially recognized in 2005, it is 
yet to be incorporated into the Centers for Disease Control and Prevention of United 
States of America (CDC) system (Su & Chiu, 2007). The Salmonella classification 
system used at the CDC is based on recommendations by the World Health 
Organization (WHO) Collaborating Centre for Reference and Research on 
Salmonella at the Pasteur Institute, Paris, France, which is responsible for updating 
the scheme (Su & Chiu, 2007). 
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Table 1.1: Nomenclature of Salmonella (adapted from Su & Chiu, 2007) 
Taxonomic position (writing format) and nomenclature No. of 
serotypes in 
each species 
or subspecies 
Genus 
(capitalized, italic) 
Species 
(italic) 
Subspecies 
(italic) 
Serotypes (or serovars) 
(Capitalized, not italic)* 
Salmonella enterica enterica (or subspecies I) 
Choleraesuis, Enteritidis, 
Paratyphi, Typhi 
1504 
  salamae (or subspecies II) 9, 46:z:z39 502 
  arizonae (or subspecies IIIa) 43:z29:- 95 
  diarizonae (or subspecies IIIb) 6,7:1, v:1,5,7 333 
  houtenae (or subspecies VI) 21 :m, t:- 72 
  indica (or subspecies VI) 59:z36:- 13 
 bongori subspecies V 13,22:z39:- 22 
 subterranea    
*some selected serotypes (serovars) are listed as examples 
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1.1.2  Laboratory Identification of S. Typhi 
Currently there are two major methods for identification of S. Typhi in a laboratory 
setting; the conventional bacteria culture method and the polymerase chain reaction 
(PCR) “serotyping” method. The bacteria culture method requires less skill but is 
more time consuming compared to the PCR “serotyping” method. 
 
In the conventional method, the bacteria sample is cultured in a selective medium 
such as Xylose-Lysine-Desoxycholate (XLD) medium to determine whether the 
bacteria belong to the genus Salmonella. Transparent colonies of bacteria with a 
black dot in the center are an indication of the genus Salmonella. The Salmonella 
bacteria will be subjected to a series of biochemical tests where their biochemical 
properties will be used to determine their species (Table 1.2). Subsequently, 
serological tests using specific antisera targeting the somatic (O), flagellar (H) and 
capsular envelop (Vi) antigens, were carried out to serotype the organism (Table 1.3) 
(WHO, 2003). 
 
In PCR “serotyping” method, specific primers are used to amplify specific antigen-
coding genes, such as prt and tyv which code for the somatic O antigens; flicC codes 
for flagellar H antigen, and viaB gene which codes for Vi antigen in S. Typhi 
(Wattiau et al., 2011). PCR “serotyping” method provides more reliable results 
compared to conventional serotyping as the Vi antigen might not be expressed in 
certain laboratory conditions (Wain et al., 2005).  
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Table 1.2: Biochemical tests for identification of S. Typhi (adapted from WHO, 
2003) 
Organism 
Triple Sugar Iron Test 
Motility, Indol, Urea 
Tests 
Citrate 
Test 
Slant Butt H2S Gas Motility Indol Urea 
S. Typhi Alkaline Acid Wk+ - + - - - 
S. Paratyphi A Alkaline Acid - + + - - - 
Other Salmonella 
spp. 
Alkaline Acid V V + - - V 
E. coli Alkaline Acid - + + + - - 
Klebsiella spp. Acid Acid - + - V + + 
Citrobacter spp. V Acid + + + V - + 
Proteus spp. Alkaline Acid + + +  + V 
 
„+‟ = Positive 
„-‟ = Negative  
Wk+ = Weak positive 
V = Variable result 
H2S = Hydrogen sulphide 
 
Table 1.3: Serological identification of S. Typhi (adapted from WHO, 2003) 
Serotype O antigen H antigen Serogroup Phase 1:2 
S. Typhi 9, 12 (Vi) d: Group D1 
S. paratyphi A 1, 2, 12 a: (1, 5) Group A 
S. paratyphi B 1, 4, (5), 12 b: 1, 2 Group B 
S. paratyphi C 6, 7, (Vi) c : 1, 5 Group C1 
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1.2 Typhoid Fever 
Typhoid fever is a systemic infectious disease caused by the bacteria S. Typhi 
(Maskalyk, 2003; WHO, 2003). Typhoid transmission is mostly by means of the 
fecal-oral route, where consumption of contaminated water or food may lead to 
typhoid (Luxemburger & Dutta, 2005). Typhoid requires an incubation period of 7-
14 days after ingestion of the bacteria. The length of the incubation period is 
dependent on a few factors, such as the quantity of inoculums, host factors, and 
medications. Typhoid requires a minimum inoculum size of 10
5
 organisms. 
However, in immunocompromised patients, inoculum size of 10
2
 organisms might be 
sufficient to cause clinical illness. Subjects on medications, such as antacids which 
reduces the gastric acid in the stomach also show higher susceptibility towards 
typhoid fever (WHO, 2003). 
 
1.2.1  Epidemiology of Typhoid Fever 
Worldwide, typhoid continues to be a burden to global health especially in under 
developed countries (Figure 1.1). Twenty-two million cases of typhoid fever with 
216,510 deaths annually were reported in the year 2000 during an exercise to 
estimate the global morbidity and mortality of typhoid fever (Crump et al., 2004). 
However, the number reported may be underestimated as the clinical picture of 
typhoid fever is often masked and confused with other infections. Moreover, modern 
diagnostic tests are not readily available in less developed countries such as Pakistan 
and Bangladesh where typhoid is endemic (WHO, 2003; Crump, et al., 2004; 
Khosla, 2008). Most of the patients are mainly infants, children and adolescents 
ranging from newborns to 20-year old adults (Crump et al., 2004). Older adults are 
presumably less susceptible due to frequent boosting of their immune system. Peak 
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of transmission often occurs after onset of the raining season or disasters such as 
earthquakes and tsunamis, where proper sanitation is unavailable (Sutiono et 
al., 2010).  
 
Malaysia is considered as one of the Southeast Asian countries endemic for typhoid 
fever (Figure 1.1). Two hundred and ten cases of typhoid fever was reported by the 
Ministry of Health in year the 2010 (Figure 1.2). Among all the states in Malaysia, 
Kelantan has the highest incidence rate in the year 2010 (Figure 1.3). Kelantan is a 
typhoid endemic state located in the North-East coast of Peninsular Malaysia. The 
incidence rate in Kelantan could rise up as high as 56.7 per 100,000 population as 
observed in the year 2005 (Figure 1.4). As a result of continuous intervention 
programs by the local health authority, the incidence rate decreased to 3.0 per 
100,000 population in 2010 (Kementerian Kesihatan Malaysia, 2011). 
 
1.2.2  Manifestation of Typhoid Fever 
During the first week of infection, signs and symptoms of typhoid gradually develop. 
Patients will experience gradually increasing fever, loss of  appetite, and fatigue. 
Some individuals may also develop frontal headache, dry cough and delirium which 
increases the malaise (WHO, 2003).  
 
In the second week of infection, the bacteria will emboli on the dermis layer resulting 
in red rose spots on the body (Khosla, 2008). As the bacteria proliferates, the patient 
will develop high fever (38-40°C), which has a stepwise pattern (WHO, 2003; 
Ogoina, 2011). 
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Figure 1.1: Global distribution of typhoid fever in the year 2000 (Adapted 
from Crump et al., 2004). 
 
 
 
 
Figure 1.2: Number of Typhoid fever cases in Malaysia from year 2006-2010 
(Kementerian Kesihatan Malaysia, 2011). 
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Figure 1.3: Incidence of typhoid fever in all states in Malaysia in the year 
2010 (Kementerian Kesihatan Malaysia, 2011). 
 
 
 
Figure 1.4: Incidence of typhoid fever in Kelantan from year 2000-2010 
(Kementerian Kesihatan Malaysia, 2011). 
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In the third week, febrile typhoid patients will experience severe abdominal 
distension may occur to some patients causing foul green liquid diarrhea (WHO, 
2003). At this stage, the patient is characterized by apathy, confusion and even 
psychosis. Necrosis of the Peyer‟s patches may cause intestinal perforation and 
peritonitis (Everest et al., 2001). At this point, overwhelming toxaemia may cause 
intestinal hemorrhage resulting in death (Lott et al., 1980; WHO, 2003). 
 
The patient may slowly recover if he survives through the fourth week but will 
require a few months to regain weight. Although the patient is cured, some may 
become asymptomatic typhoid carriers, which are capable of transmitting the 
bacteria unconsciously to other individuals (WHO, 2003; Gonzalez-Escobedo, 2011). 
 
1.2.3  Typhoid Carriers 
Prescription of antibiotics is the most common and effective way of treating typhoid 
fever. However, only 95% of typhoid patients fully recover from the disease; the 
remaining 5% become asymptomatic carriers (WHO, 2003; Gonzalez-Escobedo, 
2011). In general, a typhoid carrier is a person who harbours S. Typhi in his body 
without showing any clinical signs or symptoms. Carriers are mostly former typhoid 
patients who continue to excrete the bacteria in their stools or urine for longer than 
one year after the onset of acute typhoid fever (WHO, 2003). Carriers without a 
history of acute typhoid fever have also been reported in endemic areas (WHO, 
2003). Patients with cholelithiasis are predisposed to develop the carrier state 
(Levine, et al., 1982).  
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After ingestion of S. Typhi, the bacteria passes through the digestive track and 
reaches the small intestine. They rapidly penetrate into the mucosal epithelial cells 
and emerge in the lamina propria when they elicit an influx of macrophages. These 
macrophages ingest them but do not generally kill them (Monack et al., 2004). They 
remain hidden within the macrophages and are circulated throughout the body by 
means of the lymphatic and blood circulatory systems (WHO, 2003). It is believed 
that during the acute stage of infection, the bacteria also invades many other organs, 
such as the liver, lymphatic system, bone marrow, nerve neuron system and 
gallbladder. Among these organs, the gallbladder is the preferred niche area for 
infection (Gonzalez-Escobedo et al., 2011). 
 
Typhoid carriers are capable of shredding S. Typhi into the environment and 
infecting the community. The situation is more critical when the carriers work as 
food-handlers, such as road-side hawkers or housewives (WHO, 2003). Due to the 
asymptomatic nature of these individuals, identification of typhoid carriers is 
difficult. Typhoid carriers are not aware of their condition until an outbreak occurs 
and the source of infection is traced back to them by the public health authority 
(WHO, 2003). 
 
Typhoid carriers are usually treated immediately upon diagnosis with high dosages 
of antibiotics. According to WHO recommendations, ampicillin (100 mg per kg per 
day) plus probenecid (1 g orally or 23 mg per kg body weight for children) or 
trimethoprim-sulfamethoxazole (1600 to 800 mg twice daily) for 6 weeks, will be 
sufficient to treat most carrier cases (WHO, 2003). Cholecystectomy is usually 
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recommended for carriers with abnormal gallbladder problems, such as gallstones in 
order to cure the disease completely (Levine et al., 1982; WHO, 2003). 
 
1.3 Biofilm 
Biofilms are generally defined as a community of bacteria adherent on a surface and 
forming a protective layer of matrix (Prakash, et al., 2003). Biofilm formation is a 
protective mechanism of the bacteria in response to harsh conditions, such as 
environmental stresses, antibiotics, disinfectants and the host immune response 
(Flemming & Wingender, 2010). 
 
1.3.1  Life Cycle of Biofilm Cells 
Biofilm formation commence with a few free swimming planktonic cells attaching 
themselves onto a desired surface (Figure 1.5). The attached surface could be a biotic 
surface, such as animal cells, plant cells, or abiotic surface such as gallstone and 
polystyrene (Steenackers et al., 2012). The attachment is believed to be irreversible 
as most of the attached cells lose their motility capability such as flagella (Monroe, 
2007). The attached cells will eventually form a matrix of extracellular polymeric 
substances (EPS). The EPS matrix provides structural support and protection for the 
cells within it. As the biofilm matures, the biofilm structure becomes more complex. 
When the biofilm reaches a certain maturity level, planktonic cells or a portion of the 
biofilm may disperse into the environment seeking better habitats (Prakash et al., 
2003). 
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Figure 1.5: Life cycle of biofilm cells. Stage 1, the planktonic cells attach onto 
a surface. Stage 2, the surface-attached cells form a layer of 
protective matrix which later becomes the biofilm community. 
Stage 3, the biofilm becomes mature and disperse into the 
environment (adopted from Sauer, 2003). 
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1.3.2  Biofilm and Chronic Diseases 
Biofilm plays an important role in persistence of chronic diseases. According to the 
National Institution of Health, more than 60% of persistent bacterial infections are 
caused by biofilms (Lewis, 2001). Manifestation of bacterial biofilm-associated 
diseases ranges from mild dental plague to chronic diseases such as cystic fibrosis 
(Parsek & Singh, 2003). Distinguishing biofilm infection from acute infection is a 
tedious task as biofilm infection may coexist with acute infection. Furthermore, there 
is no known biomarker for the biofilm state. However, biofilm infection could still be 
identified based on a few fundamental characteristics of the biofilm such as; a) the 
infecting bacteria are adherent onto a surface; b) examination of the infected tissues 
show signs of bacteria clustering, or microcolonies enclosed in a matrix; c) the 
infection is usually confined to a particular area; d) the infection requires higher 
dosage or is unable to be eliminated with antibiotics (Parsek & Singh, 2003). Cystic 
fibrosis is one of the chronic diseases caused by Pseudomonas aeruginosa biofilm 
(Moreau-Marquis et al., 2008). This infection can persist in the patient for years or 
even decades. Chronic cystic fibrosis infection causes inflammation in the patient‟s 
lungs. As the lung‟s function decline, the patient suffers from respiratory failure. 
 
1.3.3  Biofilm Protein Studies 
Biofilm-associated diseases are usually chronic and difficult to eradicate; hence it 
poses a threat to human society from the point of medical healthcare (Lewis, 2001). 
To eradicate the biofilm, one must understand the nature of the biofilm. Biofilm 
arises from planktonic cells attached onto a surface. By logic the genome of 
planktonic and biofilm cells should be the same, yet the morphology and the 
behaviours of planktonic cells and biofilm cells are totally different (Donlan, 2002). 
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A simple explanation for this phenomenon is that the bacteria alters its protein 
expression dramatically in the planktonic state in order to become biofilm cells 
(Sanchez et al., 2011). Studies on various bacteria biofilms showed that there are 
significant differences in protein expression of biofilm cells and planktonic cells. 
Apart from the up regulation and down regulation of common proteins, novel biofilm 
proteins have also been found in a comparative proteomic study of Streptococcus 
suis. In addition, some biofilm proteins were found to be immunogenic which have 
potential as diagnostic markers (Wang et al., 2012).  
 
1.4 Protein Analysis and Identification  
1.4.1  Two-Dimensional Polyacrylamide Gel-Electrophoresis (2D-PAGE) 
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) is a powerful 
technique used to separate proteins based on their isoelectric points and molecular 
masses (Person et al., 2006; Posch, 2008). Single dimension SDS-PAGE method 
separates proteins based on their molecular weight. However, this method is not ideal 
when the samples contain more than one protein that have the same molecular 
weight. These proteins will appear as one band on the gel but consist of two or more 
proteins. In order to distinguish them, another stage of separation is needed (Liebler, 
2001).  
 
Proteins are a polymer chain containing various amino acids with different chemical 
properties. Combination of these amino acids give the protein polymer different 
physical and chemical properties and functions. Amphoteric molecules carry charges 
either positive or negative depending on the surrounding pH. When an electric field 
is applied to these molecules, they will migrate toward a certain pH zone where they 
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could become neutral; the point where a certain amphoteric molecule becomes 
neutral is defined as the isoelectric point (PI) (Liebler, 2001; Geiser et al., 2011). 
 
2D-PAGE separates proteins based on isoelectric focusing (IEF) in the first stage and 
molecular mass in the second stage. In the first stage, the protein sample is absorbed 
onto a pH gradient dried gel strip and the gel is hydrated. When an electric current is 
applied to the gel, acidic proteins at the alkaline side will be ionized and become 
negatively charged and migrate towards lower pH side (acidic) on the gel, whereas 
the alkaline protein at the acid side will become positively charged and migrate 
toward higher pH (alkaline) side on the gel. These proteins will eventually reach a 
point (isoelectric point) where they become neutral by losing their charge and stop 
moving. In the second stage, the proteins are separated by SDS-PAGE based on the 
molecular mass of the proteins (Garfin, et al., 2003). Thus, as a result the 2D gel will 
have spots of proteins separated by means of isoelectric focusing and molecular 
mass. 
 
1.4.2  Mass Spectrometry 
Mass Spectrometry (MS) is a powerful analysis tool used for rapid and accurate 
measurement of molecular mass of a sample. It is widely used in various fields, such 
as protein analysis in biotechnology, drug discovery in pharmaceuticals, drug testing 
in clinical settings and pesticide quantitation in the environmental. MS is highly 
accurate and reproducible. It is able to determine the molecular mass of organic 
compounds up to an accuracy of 5 parts per million (ppm) (Ashcroft, 1997). Due to 
the high accuracy, identification of protein peptides can be done by confirming the 
peptide mass against a protein database. 
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In general, MS can be divided into three fundamental components, the ionization 
source, analyzer and the detector. The ionization source provides energy for the 
molecules to be vaporized into ionic form (Ashcroft, 1997). The analyzer separates 
these ions base on their mass to charge ratio (m/z) and the detector detects these ions 
as electronic signals at the end of the detector and analyze them based on their 
relative abundance quantity and molecular weight in the form of the m/z spectrum 
(Ashcroft, 1997). 
  
Technology advances as time passes. Currently there are many varieties of mass 
spectrometry methods, the most widely used in biochemical studies is the Matrix 
Assisted Laser Desorption Ionization (MALDI). MALDI is compatible with thermo 
labile, non-volatile, and high molecular mass organic compounds. Proteins, 
glycoproteins, oligosaccharides are highly recommended (Lim, et al., 2003). Bacteria 
protein analysis has also achieved a great deal of successes using MALDI (Murray, 
2010). MALDI uses a laser bombardment-based ionization technique. The samples 
are pre-mixed with a matrix which have a high energy absorbent component such as 
Alpha-cyano-4-hydroxycinnamic acid (ACHA) (Hernandez-Guillamon et al., 2010). 
The matrix absorbs and transfers the excitation energy to the samples which lead to 
sputtering of ions from the surface to the analyzing chamber. The excited ions are 
analyzed based on their Time of Flight (TOF) signals, as the ions travel through the 
analyzing chamber, molecules with lower m/z ratio (lighter molecules) will travel 
faster while molecules with higher m/z ratio (heavier molecules) will travel slower 
towards the detector (Ashcroft, 1997; Downard, 2004).  
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There are two modes available in mass spectrometry data analysis; 1) MS or Protein 
Mass Fingerprint (PMF), and 2) MS/MS (tandem MS). MS data is the mass of the 
total peptides, and MS/MS data is the mass of each peptide further fragmented by gas 
collision. For protein identification, the MS data is normally sufficient to provide 
identity of the protein. However with the MS/MS data, the results can be presented 
with more confidence (Webster & Oxley, 2012). 
 
1.5 Rational of the Study 
Today, sanitation and clean water supply have greatly decreased the number of cases 
and outbreaks of typhoid fever. However, the threat still remains. Persistence of 
typhoid carriers is the main reason why typhoid still exist today. To reduce the 
frequency of typhoid outbreaks, carriers must be identified and treated as soon as 
possible. Currently, typhoid carriers are identified using stool culture method (Wain 
et al., 1998). Stool samples are collected from treated patients one year after the 
onset of acute typhoid fever and cultured for the presence of S. Typhi (WHO, 2003). 
However, this method has low sensitivity since only 1-5% of carriers are detected by 
stool or rectal swab culture methods (Wain, et al., 1998; WHO, 2003). Also, stool 
sample collection and bacteria cell culture are tedious procedures. Serological 
methods which depend on detection of elevated IgA and/or IgG antibodies against S. 
Typhi antigens require paired sera which are not easily obtainable. 
 
False negative diagnose of typhoid carriers might lead to outbreaks of the disease as 
these carrier subjects are usually unaware that they are still shredding the bacteria 
into the environment that might infect other people. The situation may become 
crucial if the carrier is a food-handler, such as a chef or roadside hawker, and cause 
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outbreaks of the disease. In order to detect typhoid carriers efficiently, a simple but 
sensitive test based on proteins specific to S. Typhi in the carrier state should be 
made available. Hence, this has become the thrust of this research. 
 
In this study, we hypothesized that the typhoid carrier state is associated with biofilm 
formation by S. Typhi sequestered in the gallbladder of its victims. Biofilm 
formation protects S. Typhi from bile and other environmental stress in the 
gallbladder. Since biofilm is associated with bacterial persistence, it is proposed that 
biofilm cells represent the carrier state, whereas the planktonic (free swimming) cells 
represent the acute state of the disease. However, since S. Typhi is a human-specific 
pathogen, no animal model system is available to culture the organism and produce 
biofilm for laboratory analysis. Hence, an important aim of this study was to develop 
an in vitro method for production of S. Typhi biofilm cells by culturing the pathogen 
under conditions that mimic the gallbladder environment. Apart from that, by 
comparing the protein expression profiles of the planktonic and biofilm cells using 
2D gel electrophoresis and gel image processing technology, biofilm proteins may be 
uncovered that may have potential to be used as laboratory diagnostic biomarkers for 
detection of typhoid carriers. 
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1.6 Objectives of the Study 
The goal of this study was to identify potential proteins that are important for 
development of S. Typhi biofilm under in vitro gallbladder environment. The 
experimental overview of this study is shown in Figure 1.6. This study was divided 
into 4 phases, which include: 
 
Phase I  Development of an in vitro S. Typhi biofilm culture method by 
mimicking the gallbladder environment 
 To determine the ingredients needed for of S. Typhi biofilm culture  
 To optimize the factors affecting S. Typhi biofilm production 
 
Phase II  Elucidation of proteins expressed in S. Typhi biofilm 
 To grow and extract both planktonic and biofilm proteins 
 To analyze planktonic and biofilm proteins using 2D-PAGE 
 To identifly novel biofilm proteins spot using MALDI-TOF 
 
Phase III  Investigation of the effect of bile on TolC protein expression 
 To establish optimal concentration of bile needed for TolC production 
 To analyze the TolC protein profile using 2D-PAGE 
 
Phase IV  Antibiotic resistance study of S. Typhi biofilm  
 To grow biofilm in different concentrations of various antibiotics 
 To elucidate the effect of various antibiotics on biofilm growth 
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Figure 1.6: Flow chart of research experimental overview. 
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CHAPTER 2.0 
MATERIALS AND METHODS 
 
2.1 Materials 
2.1.1  Chemicals, Media and Reagents 
Chemicals, media and reagents used in this study are listed in Table 2.1. 
 
2.1.2  Research Kits and Consumables  
Research kits and consumables used in this study are listed in Table 2.2. 
 
2.1.3  Software  
Software used in this study is listed in Table 2.3. 
 
2.1.4  Instruments 
Instruments used in this study are listed in Table 2.4. 
 
2.1.5  Bacteria Isolates 
Bacteria isolates used in this study are listed in Table 2.5. 
 
2.1.6  Enzymes and Antibiotics 
Enzymes and antibiotics used in this study are listed in Table 2.6. 
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Table 2.1: List of chemicals, media and reagents 
No. Name Source 
1.  
3-dimethylammonio-2-hydroxy-1-propanesulfonate 
(CHAPS) 
Amresco, USA 
2.  Acetic acid glacial Merck, Germany 
3.  Acetonitrile (ACN) Sigma-Aldrich, USA 
4.  Acrylamide / bis solution 37.5:1 30% Bio-Rad, USA 
5.  Alpha-cyano-4-hydroxycinnamic acid (ACHA) Sigma-Aldrich, USA 
6.  Amidosulfobetaine-14 (ASB-14) CALBIOCHEM, UK 
7.  Ammonium bicarbonate (ABC) Sigma-Aldrich, USA 
8.  Ammonium persulfate (APS) Bio-Rad, USA 
9.  Ampholytes 3-10 Bio-Rad, USA 
10.  Bile purified Fluka, USA 
11.  Bromophenol blue Bio-Rad, USA 
12.  Complete EDTA-free protease inhibitor cocktail Roche, Germany 
13.  Coomassie blue R250 Bio-Rad, USA 
14.  Crystal Violet dye Riedel-de Haën, USA 
15.  Dithiothreitol (DTT) Bio-Rad, USA 
16.  Ethanol HmbG chemical, Germany 
17.  Glucose (D+) Sigma-Aldrich, USA 
18.  Glycerol Merck, Germany 
19.  Iodoacetamide (IAA) Bio-Rad, USA 
20.  Kovac reagents Remel, UK 
21.  Methanol Merck, Germany 
22.  Methyl red solution Remel, UK 
23.  Methyl red Vogas-Proskauer (MRVP) medium Oxoid Ltd, UK 
24.  Mineral oil Bio-Rad, USA 
25.  Nutrient broth powder Oxoid Ltd, UK 
26.  Potassium chloride (KCl) Merck, Germany 
27.  Simmons citrate Agar Oxoid Ltd, UK 
28.  Sodium chloride (NaCl) Merck, Germany 
29.  Sodium dodecyl sulphate (SDS) Bio-Rad, USA 
30.  β-mercaptoethanol Bio-Rad, USA 
31.  Sulfobetaine (SB 4-10) CALBIOCHEM, UK 
32.  Sulphate Indole Motility (SIM) medium Oxoid Ltd, UK 
33.  Thiourea Sigma-Aldrich, USA 
34.  Trifluoroacetic acid (TFA) Sigma-Aldrich, USA 
35.  Triple Sugar Iron (TSI) agar Oxoid Ltd, UK 
36.  Tris (hydroxymethyl) aminomethane (TRIS) Bio-Rad, USA 
37.  Urea Amresco, USA 
38.  Urea agar base Oxoid Ltd, UK 
39.  Xylose Lysine Deoxycholate (XLD) agar Oxoid Ltd, UK 
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Table 2.2: List of research kits and consumables 
No. Name Source 
1. 96-well not coated cell culture microtiter plates Nunc, USA 
2. Antisera poly O, poly H, H-d, Vi and 09 Remel, USA 
3. Bovine serum albumin (BSA) solution Bio-Rad, USA 
4. Immobilized pH gradient (IPG) strip Bio-Rad, USA 
5. Micro-centrifuge tubes 2.0 ml, 1.5 ml, 0.6 ml, 0.2 ml Axygen, USA 
6. Pipette tips 5.0 ml, 1.0 ml, 200 µl, 10 µl  Axygen, USA 
7. RCDC protein concentration assay Bio-Rad, USA 
8. Zip Tip Milipore, USA 
 
Table 2.3: List of software 
No. Name Purpose Source 
1. Soft-Max Pro Series 5  Optical density analysis Molecular device , USA 
2. PDQuest 2D-PAGE gel analysis Bio-Rad, USA 
3. MASCOT Search Peptides identification Matrix Science, USA 
4. Unistat Statistic analysis  Unistat Ltd, UK 
 
Table 2.4: List of instruments 
No. Name Source 
1. Autoclave machine Hirayama, Japan 
2. Bath sonicator Illinois, USA 
3. Centrifuge machine Eppendorf, USA 
4. Chiller (4ºC) Hitachi, Japan 
5. Deep freezer (-70ºC) Thermo scientific, USA 
6. Freezer (-20ºC) Sanyo, Japan 
7. IEF system Bio-Rad, USA 
8. Incubator  Memmert, Germany 
9. Incubator shaker Thermo scientific, USA 
10. Microscope Olympus, Japan 
11. Mini Protean II Bio-Rad, USA 
12. Orbital shaker Finemould precission, Korea 
13. pH meter Villerbanne Cedey, France 
14. Refrigerator centrifuge Eppendorf, USA 
15. ELISA spectrophotometer Molecular device, USA 
16. Ultrasonicator Misonix Incoperated, USA 
17. Vortex ERLA, USA 
18. Weighing Machine A&D company limited, Japan 
19. Densitometer Bio-Rad, USA 
20. Vacuum concentrator Eppendorf, USA 
21. MALDI-TOF/TOF 5800 AB Sciex, USA 
  
